quantdetect

QD was not selected a startup pitch finalist in the Nikkei shimbun and Medpeer organized event. Thanks for your support!

QD is selected last 52 startups in the Nikkei shimbun and Medpeer organized event. More to go for the final. 

On Oct 28, 2022, Fri, Nishizuka will speak about our business in “Securite Night”. Anybody’s welcome and we look forward to seeing you in person!

On Oct 21, 2022, Fri, we hold an online webinar “fund for technology development in cancer recurrence monitoring”.

Quantdetect, Inc. was highlighted in “DX(digital transformation) ties solution” of The Nikkan Kogyo Shimbun.

Nishizuka gave a talk in a symposium “practice and research successful case reports” at the 42nd Japan Society for Molecular Tumor Marker Research.

Great support voices are now up at the crowdfunding site.

Our collaborator, Takeshi Iwaya, M.D., Ph.D. presented OTS-Assay at a luncheon seminar sponsored by LSI Medience/Finggal Link in the 76th The Japan Esophageal Society Annual Meeting.

JOQU-FM FM IWATE    Now online! Nishizuka introduced OTS-Assay in Iwate Medical University Broadcast Program.

Internship students from Morioka business consortium (tent) navigated by FVC Tohoku visited in Morioka Llab.